Anesiva news from FierceBiotech
NewsAnesiva axes staff, preclinical work in restructuring
Anesiva is axing its preclinical development program as well as other "non-core positions" and reducing its head count by 20 percent as it restructures to focus on late-stage products and sales as Read more...
SPOTLIGHT: Anesiva inks $114M licensing deal
Transcription Factor Therapeutics has licensed the worldwide rights to Anesiva's NF-kB Decoy program, which includes the clinical drug candidate Avrina. NF-kB Transcription Factor Decoy inhibits Read more...
ALSO NOTED: Zingo data lifts Anesiva stock; Two chemo drugs win approvals; BrainStorm plans trials; and much more...
> Shares of Anesiva jumped after the company announced positive top-line data from a late-stage study of Zingo, its drug candidate for reducing venous procedural pain. Read more...
ALSO NOTED: Vernalis reports "striking" weight loss in trial; Genmab shares surge on Phase III; FDA wants more time on Entereg;
> Vernalis is reporting "striking" weight loss results in its Phase I trial of the obesity drug V24343. Read more...
FDA approves Anesiva's needle-free pain drug
The FDA has given Anesiva a nod for Zingo, a single-use, needle-free system containing sterile lidocaine powder. Zingo provides rapid relief for pain associated with venous access procedures, such Read more...
| Press ReleasesPRESS RELEASE: Anesiva Announces Pivotal Phase 3 Trial of Zingo Meets Primary Endpoint Anesiva Announces Pivotal Phase 3 Trial of Zingo Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults Company Plans to File Supplemental New Drug Application with FDA in Read more... PRESS RELEASE: Anesiva Initiates New Phase 2 Trial of Adlea Anesiva Initiates New Phase 2 Trial of Adlea for Pain Relief Following Knee Replacement Surgery Adlea May Provide Pain Relief Without Opiate-Like Side Effects For Several Months Following a Single Read more... PRESS RELEASE: Anesiva Receives FDA Approval for Zingo, a Product to Reduce Pain Associated with Needle Insertion ProceduresAnesiva Receives FDA Approval for Zingo, a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children - Zingo is First Commercial Product for Anesiva - SOUTH SAN Read more... |
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets